Albireo Pharma, Inc. announced the appointment of Pamela Stephenson, MPH, as Chief Commercial Officer, effective March 25, 2019. In the newly created leadership position, Stephenson will be responsible for overseeing the company’s commercial strategy and global commercial operations. Stephenson has more than 20 years of biopharma commercial leadership experience across multiple functions and disease areas. Before joining Albireo, Stephenson served as Vice President, Global Market Access and Value, at Vertex Pharmaceuticals, where she led the global market access and pricing strategy for current and future products. Earlier in her tenure at Vertex, she led marketing and sales activities for the company’s hepatitis C and cystic fibrosis lines of business, and oversaw the U.S. launches of Incivek® (telaprevir) and Orkambi ®(lumacaftor/ivacaftor).